Best hospitals for oncology: A data-based international review
What international rankings show
The 2026 Newsweek and Statista World’s Best Specialized Hospitals ranking places Memorial Sloan Kettering Cancer Center in New York City first for oncology, followed by MD Anderson Cancer Center in Houston. Samsung Medical Center and Asan Medical Center, both in Seoul, rank third and fourth, while Mayo Clinic in Rochester ranks fifth. The ranking includes 300 oncology hospitals and uses peer recommendations, professional accreditations, and patient-reported outcomes as evaluation criteria. 1
| Rank | Hospital | City and country |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer Center | New York City, United States |
| 2 | MD Anderson Cancer Center | Houston, United States |
| 3 | Samsung Medical Center | Seoul, South Korea |
| 4 | Asan Medical Center | Seoul, South Korea |
| 5 | Mayo Clinic, Rochester | Rochester, United States |
The leading ten oncology hospitals
The remainder of the Newsweek top ten includes Gustave Roussy in Villejuif, France; The Royal Marsden Hospital in London; Seoul National University Hospital; The Princess Margaret Cancer Centre in Toronto; and The Johns Hopkins Hospital in Baltimore. The geographic spread indicates that leading oncology care is concentrated in several major academic systems across North America, Europe, and Asia rather than in one country alone. 1
| Rank | Hospital | Location |
|---|---|---|
| 6 | Gustave Roussy | Villejuif, France |
| 7 | The Royal Marsden Hospital | London, United Kingdom |
| 8 | Seoul National University Hospital | Seoul, South Korea |
| 9 | The Princess Margaret Cancer Centre | Toronto, Canada |
| 10 | The Johns Hopkins Hospital | Baltimore, United States |
Why U.S. rankings can produce different results
International and national rankings measure different comparison groups and may therefore produce different leaders. Newsweek ranked Memorial Sloan Kettering first globally for oncology in 2026, whereas U.S. News and World Report’s 2026 to 2027 U.S. cancer-care ranking placed MD Anderson first nationally, with Memorial Sloan Kettering second. MD Anderson has held the U.S. News first position for cancer care for 12 consecutive years and has ranked first or second since the survey began in 1990. 3 4
| Assessment | First-ranked hospital | Second-ranked hospital |
|---|---|---|
| Newsweek World’s Best Specialized Hospitals 2026, oncology | Memorial Sloan Kettering Cancer Center | MD Anderson Cancer Center |
| U.S. News 2026 to 2027, U.S. cancer care | MD Anderson Cancer Center | Memorial Sloan Kettering Cancer Center |
How patients can assess institutional fit
A high overall ranking does not establish that a hospital is the strongest match for every diagnosis. Cancer type, stage, treatment complexity, physician credentials, experience with the specific disease, access to multidisciplinary care, insurance participation, travel requirements, and communication preferences all affect the practical value of a hospital. Patients are also advised to review expected treatment volume, available outcomes data, accreditation, and the possibility of obtaining a second opinion. 10
- Determine whether the program treats the specific cancer and stage regularly.
- Ask whether medical oncology, radiation oncology, surgery, pathology, imaging, genetics, and supportive care are coordinated.
- Review clinical-trial availability when standard treatment options are limited.
- Confirm physician credentials, hospital accreditation, insurance arrangements, and travel logistics.
- Compare the proposed treatment plan with evidence-based recommendations such as NCCN guidelines. 14
Research, clinical trials, and specialized programs
Research capacity is a major differentiator among comprehensive cancer hospitals. MD Anderson describes a mission combining patient care, research, education, and prevention, while Memorial Sloan Kettering reports that laboratory discoveries are translated into new treatments. Dana-Farber, Mayo Clinic, and other academic centers similarly combine oncology treatment with research and clinical-trial programs. Trial access can be particularly relevant for rare cancers, treatment-resistant disease, or newly developed therapies, but eligibility depends on diagnosis, prior treatment, health status, and protocol requirements. 3 5 15

- Montefiore Einstein Comprehensive Cancer Center reports more than 500 active clinical research studies and treatment across more than 400 cancer types. 6
- UF Health Cancer Institute reports nearly 200 clinical trials, more than $55 million in annual cancer research funding, and 375 institute members. 7
- Stephenson Cancer Center is Oklahoma’s only NCI-designated cancer center and reports more than 250 ongoing biomedical research projects. 9
- NCI designation reflects scientific leadership, research resources, and the ability to conduct innovative cancer research and patient-focused studies. 11
Risks, limitations, and practical constraints
Rankings should be treated as starting points rather than clinical recommendations. They may combine expert opinion, institutional reputation, accreditation, patient-reported outcomes, and other measures that do not directly predict an individual patient’s outcome. Treatment can also involve substantial travel, coordination, waiting periods, insurance restrictions, language barriers, and the need for follow-up near home. National rankings should therefore be supplemented with cancer-specific information and a discussion with qualified clinicians familiar with the patient’s case. 1 10
- Do not assume that the highest-ranked general oncology program leads in every cancer subtype or procedure.
- Verify whether a clinical trial is accepting participants and whether eligibility criteria are met.
- Ask how urgent treatment decisions, complications, rehabilitation, pain management, and survivorship care will be handled.
- Consider continuity between the specialist hospital and local clinicians after treatment.
- Use professional quality programs, including ASCO’s Quality Oncology Practice Initiative, as one additional source of practice-assessment information. 13
Additional hospitals identified in the data
The global ranking also places IEO in Milan, Charité in Berlin, National Cancer Center Hospital in Tokyo, Peter MacCallum Cancer Centre in Melbourne, Dana-Farber Brigham Cancer Center in Boston, Massachusetts General Hospital, Hospital Israelita Albert Einstein in São Paulo, Heidelberg University Hospital, Hospital Sírio-Libanês, Cleveland Clinic, Institut Curie, Severance Hospital, The Christie, and Cancer Institute Hospital of JFCR among the listed oncology institutions. These results reinforce the importance of comparing programs by specialty, location, research activity, and patient needs rather than relying on a single ordinal position. 1
| Region represented | Examples from the ranking |
|---|---|
| United States | Dana-Farber Brigham Cancer Center, Massachusetts General Hospital, Cleveland Clinic |
| Europe | Charité, Heidelberg University Hospital, Institut Curie, The Christie |
| Asia-Pacific | National Cancer Center Hospital, Peter MacCallum Cancer Centre, Cancer Institute Hospital of JFCR |
| Latin America | Hospital Israelita Albert Einstein, Hospital Sírio-Libanês |
Sources
- Newsweek and Statista, World’s Best Specialized Hospitals 2026, Oncology
- Oncology News Central, Annual Oncology Hospital Rankings Released
- UT MD Anderson Cancer Center, 2026 U.S. News cancer-care ranking release
- Healio, UT MD Anderson once again named nation’s best cancer hospital
- Memorial Sloan Kettering Cancer Center, MSK Honors in 2025 and institutional information
- Montefiore Einstein Comprehensive Cancer Center
- UF Health Cancer Institute
- UCI Health cancer-services ranking
- OU Health Stephenson Cancer Center
- General oncology selection guidance provided in the research data
- National Cancer Institute, NCI-designated cancer centers
- U.S. News and World Report, Best Hospitals cancer ranking
- American Society of Clinical Oncology, Quality Oncology Practice Initiative
- National Comprehensive Cancer Network, clinical practice guidelines
- Mayo Clinic Cancer Center and clinical-trial information
Authored by MistyMountainView team